2021 annual financial data
Neuropace 2021 Operating cash flow margin
Neuropace 2021 operating cash flow margin with verified reported values.
Direct answer
Operating cash flow margin was -54.39%.
Operating income was -23,737,000 USD and net income was -36,080,000 USD.
Operating cash flow was -24,577,000 USD.
Get free Neuropace email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 45,183,000 USD
- Operating income
- -23,737,000 USD
- Net income
- -36,080,000 USD
- Operating cash flow
- -24,577,000 USD